A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients with osteoarthritis
Crossref DOI link: https://doi.org/10.1007/BF03351533
Published Online: 2014-06-07
Published Print: 2001-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Truitt, K. E.
Sperling, R. S.
Ettinger, W. H. Jr.
Greenwald, M.
DeTora, L.
Zeng, Q.
Bolognese, J.
Ehrich, E.
Text and Data Mining valid from 2001-04-01
Article History
Received: 6 October 2000
Accepted: 29 January 2001
First Online: 7 June 2014